Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,143 | -14,751 |
| Depreciation Amortization | 899 | 3,055 |
| Income taxes - deferred | 27 | N/A |
| Accounts receivable | 6,626 | N/A |
| Accounts payable and accrued liabilities | -4,679 | N/A |
| Other Working Capital | 1,327 | -1,377 |
| Other Operating Activity | -3,014 | -703 |
| Operating Cash Flow | $-957 | $-13,776 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,396 | -2,869 |
| Other Investing Activity | -39 | -10,023 |
| Investing Cash Flow | $-1,435 | $-12,892 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -35 | N/A |
| Common Stock Issued | 2 | N/A |
| Other Financing Activity | -2,627 | 28,561 |
| Financing Cash Flow | $-2,660 | $28,561 |
| Beginning Cash Position | 12,137 | 10,244 |
| End Cash Position | 7,085 | 12,137 |
| Net Cash Flow | $-5,052 | $1,893 |
| Free Cash Flow | ||
| Operating Cash Flow | -957 | -13,776 |
| Capital Expenditure | -1,396 | N/A |
| Free Cash Flow | -2,353 | -13,776 |